Research Fellow
Future Industries Institute
Mawson Lakes Campus (V1-18)
tel +61 8 830 23521
Dr Ainslie Derrick-Roberts is a Research Fellow in the Regenerative Medicine Group based at Mawson Lakes, Future Industries Institute. She received her PhD from the University of Adelaide (based at the Women's and Children's Hospital, Department of Paediatrics), using small molecules to improve brain neurodegeneration in Sanfilippo syndrome. She was the Malcolm Douglas Grant Post-Doctoral Research Fellow developing models of skeletal disease in Morquio syndrome another disorder of extracellular matrix dysfunction and inflammation.
Ainslie was a member of the Plasma Medicine Group (2022-2023) developing in vitro and ex vivo models of skin biology and translating this work to preclinical models to further understand the... Read more
About me
Dr Ainslie Derrick-Roberts is a Research Fellow in the Regenerative Medicine Group based at Mawson Lakes, Future Industries Institute. She received her PhD from the University of Adelaide (based at the Women's and Children's Hospital, Department of Paediatrics), using small molecules to improve brain neurodegeneration in Sanfilippo syndrome. She was the Malcolm Douglas Grant Post-Doctoral Research Fellow developing models of skeletal disease in Morquio syndrome another disorder of extracellular matrix dysfunction and inflammation.
Ainslie was a member of the Plasma Medicine Group (2022-2023) developing in vitro and ex vivo models of skin biology and translating this work to preclinical models to further understand the mechanism of action of highly-ionised energy known as plasma. During this time Ainslie was involved in developing complex multispecies biofilm infection models in wounds and burn injury to developing novel treatments for these conditions that don't rely on antibiotic delivery. Ainslie is working with materials scientists and physical chemists to develop novel wound dressings and investigate the use of low-temperature, atmospheric-pressure plasmas for biological and medical applications particularly in regards to improving wound healing and decontamination in chronic wound settings.
In the latter part of 2023, she joined the Regenerative Medicine group and is working with Industry partner Calix on the SAAFE CRC project investigating the antimicrobial properties of magnesium oxide derived nanomaterials on wound infection in skin diseases for application in agriculture and veterinary practice. For further information of this project head to https://www.crcsaafe.com.au/research/projects/managing-infection-with-magnesium-microparticles
About me
Doctor of Philosophy The University of Adelaide
Bachelor of Medical and Pharmaceutical Biotechnology with Honours University of South Australia
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2024 |
Open access
4
3
|
| 2024 |
Open access
17
16
213
|
| 2023 |
Open access
2
3
|
| 2021 |
Open access
3
3
5
|
| 2021 |
11
11
2
|
| 2020 |
4
5
|
| 2020 |
Open access
1
1
|
| 2020 |
15
13
1
|
| 2018 |
Open access
12
12
1
|
| 2017 |
Open access
1
|
| 2017 |
Open access
17
17
2
|
| 2016 |
13
13
1
|
| 2016 |
8
8
2
|
| 2016 |
8
8
3
|
| 2015 |
10
11
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Osaka Metropolitan University | JAPAN |
| SA Pathology | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of Alabama | UNITED STATES |
| University Of Alabama In Huntsville | UNITED STATES |
| University of New South Wales | AUSTRALIA |
| University of Sheffield | UNITED KINGDOM |
| University of South Australia | AUSTRALIA |
| Women's and Children's Hospital | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 110327 - Application of plasma medicine in the treatment of burn wounds | Current |
| Investigation into methods to control the plasma jet production of reactive species for biomedical applications | Current |
